Page last updated: 2024-11-03

propranolol and Cancer of Ovary

propranolol has been researched along with Cancer of Ovary in 6 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"Our study indicates that ovarian cancer considerably alters contractile activity of the nonpregnant human uterus in response to ADRB antagonists."1.62Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies. ( Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S, 2021)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Falcinelli, M1
Al-Hity, G1
Baron, S1
Mampay, M1
Allen, MC1
Samuels, M1
Jones, W1
Cilibrasi, C1
Flaherty, RL1
Giamas, G1
Thaker, PH2
Flint, MS1
Modzelewska, B1
Jóźwik, M2
Kleszczewski, T1
Sulkowski, S1
Ramondetta, LM1
Hu, W1
Urbauer, DL1
Chisholm, GB1
Westin, SN1
Sun, Y1
Ramirez, PT1
Fleming, N1
Sahai, SK1
Nick, AM2
Arevalo, JMG1
Dizon, T1
Coleman, RL1
Cole, SW2
Sood, AK2
Lee, JW1
Shahzad, MM1
Lin, YG1
Armaiz-Pena, G1
Mangala, LS1
Han, HD1
Kim, HS1
Nam, EJ1
Jennings, NB1
Halder, J1
Stone, RL1
Lu, C1
Lutgendorf, SK1
Lokshin, AE1
Bayot, MR1
Chopra, IJ1
Steckel, RJ1
Tobin, P1
Ross, G1
Stein, JJ1
Stevens, GH1

Trials

1 trial available for propranolol and Cancer of Ovary

ArticleYear
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
    Gynecologic oncology, 2019, Volume: 154, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carc

2019

Other Studies

5 other studies available for propranolol and Cancer of Ovary

ArticleYear
Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer.
    Brain, behavior, and immunity, 2023, Volume: 110

    Topics: Animals; B7-H1 Antigen; CD8-Positive T-Lymphocytes; Female; Humans; Immunosuppression Therapy; Inter

2023
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
    Gynecologic and obstetric investigation, 2021, Volume: 86, Issue:1-2

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolami

2021
Surgical stress promotes tumor growth in ovarian carcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Apr-15, Volume: 15, Issue:8

    Topics: Adrenergic beta-Antagonists; Animals; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cytokines; Fe

2009
Coexistence of struma ovarii and Graves' disease.
    Thyroid : official journal of the American Thyroid Association, 1995, Volume: 5, Issue:6

    Topics: Adult; Antihypertensive Agents; Antithyroid Agents; Female; Graves Disease; Humans; Iodine Radioisot

1995
Radiation protection of vital organs, using a selective arterial catheter. Experimental and clinical aspects.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1969, Volume: 106, Issue:4

    Topics: Abdominal Neoplasms; Animals; Catheterization; Cystadenoma; Dogs; Epinephrine; Female; Humans; Infus

1969